Updates are available Correction dated 2023-06-05
Click to view Correction: https://doi.org/10.1186/s10194-023-01605-1
-
Authors
Greco, Rosaria
Francavilla, Miriam
Demartini, Chiara
Zanaboni, Anna Maria
Sodergren, Mikael H.
Facchetti, Sara
Pacchetti, Barbara
Palmisani, Michela
Franco, Valentina
Tassorelli, Cristina
- License Information
-
More Information
Article History
Received: 29 March 2023
Accepted: 27 April 2023
First Online: 3 May 2023
Change Date: 5 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s10194-023-01605-1
Declarations
:
: CT has received personal fees for the participation in advisory boards and/or scientific symposia from Abbvie, Dompé, Eli Lilly, Novartis, Lundbeck and Teva. Her institution has received payments for sponsored clinical trials or investigator-initiated trials from Abbvie, Eli Lilly, Novartis, Lundbeck and Teva. The other authors have no conflicts of interests to declare.
